1. China's Covid-19 vaccine candidate elicits antibody response, early-stage findings show  India Today
  2. 50 African Diplomats on Anti-Covid-19 Visit to China’s Sinopharm  Africanews English
  3. Preliminary results show Chinese COVID-19 vaccine candidate safe: The Lancet  SHINE
  4. Indonesian team in China to check COVID-19 vaccines  Anadolu Agency
  5. 50 African diplomats visit Chinese coronavirus vaccine maker  CGTN
  6. View Full coverage on Google News
More than 600 healthy volunteers participated in these early-stage trials for China's Covid-19 vaccine candidate, findings published in The Lancet Infectious Diseases journal on Thursday said.More than 600 healthy volunteers participated in these early-stage trials for China's Covid-19 vaccine candidate, findings published in The Lancet Infectious Diseases journal on Thursday said.

China's Covid-19 vaccine candidate elicits antibody response, early-stage findings show - Coronavirus Outbreak News

Russian Ambassador to Indonesia Lyudmila Vorobieva said her government had contacted the Health Ministry about the possible distribution and use of the Sputnik V vaccine and was currently waiting for its response.Russian Ambassador to Indonesia Lyudmila Vorobieva said her government had contacted the Health Ministry about the possible distribution and use of the Sputnik V vaccine and was currently waiting for its response.

Russia offers Indonesia access to Sputnik vaccine - Sat, October 17 2020 - The Jakarta Post

Inspections will be carried out at 3 companies that have agreed to supply COVID-19 vaccines to Indonesia - Anadolu AgencyInspections will be carried out at 3 companies that have agreed to supply COVID-19 vaccines to Indonesia - Anadolu Agency

Indonesian team in China to check COVID-19 vaccines

Treatment is safe and elicits an antibody response, preliminary results have shownTreatment is safe and elicits an antibody response, preliminary results have shown

'Enouraging' Chinese Covid vaccine shows early promise - Wales Online

403 Missing Auth Token

At the same time, President Putin noted that both industrial and agricultural production is growing in Karachay-CherkessiaAt the same time, President Putin noted that both industrial and agricultural production is growing in Karachay-Cherkessia

Russian unemployment problem rising, says Putin - Business & Economy - TASS

Russian unemployment problem rising, says Putin

The State Council will be headed by the Russian president. It will serve as an advisory body to the head of stateThe State Council will be headed by the Russian president. It will serve as an advisory body to the head of state

Putin introduces draft bill on creation of State Council to Russian parliament - Russian Politics & Diplomacy - TASS

Putin introduces draft bill on creation of State Council to Russian parliament

COVID-19 vaccine, and China-Africa health cooperation, are their focus.

50 African diplomats visit Chinese coronavirus vaccine maker - CGTN

news, sport, business, politics and more, from Sheffield's newspaper, The Star.

Page not found | The Star

But, er, Professor Heidi Larson also admits palace may not wish to ‘risk’ giving 94-year-old new jabBut, er, Professor Heidi Larson also admits palace may not wish to ‘risk’ giving 94-year-old new jab

Coronavirus: Queen could be used to dispel vaccine fears, government expert suggests | The Independent

BEIJING • One of China's front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early-and mid-stage test in humans, researchers said.. Read more at straitstimes.com.East Asia News -BEIJING • One of China's front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early-and mid-stage test in humans, researchers

China vaccine candidate found safe in early tests, East Asia News & Top Stories - The Straits Times

A $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said Thursday residents aged between 18 and 59 with "urgent needs" can seek consultations at clinics for a Sinovac Biotech vaccine thatA $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet

$60 experimental coronavirus vaccine rolled out in eastern Chinese city | Deccan Herald

The second phase of the study was designed to identify the optimal timing schedule for vaccination.The second phase of the study was designed to identify the optimal timing schedule for vaccination.

China has said that while reasonable profits for companies are permitted, covid-19 vaccines should be priced close to cost.Chinese authorities have to date not released pricing details for potential covid-19 vaccinesChina has said that while reasonable profits for companies are permitted, covid-19 vaccines should be priced close to cost.Chinese authorities have to date not released pricing details for potential covid-19 vaccines

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60

Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59

Preliminary results show Chinese Covid-19 vaccine candidate safe | Dhaka Tribune

The North Carolina Department of Health and Human Services released their interim COVID-19 vaccination plan Friday, once one is available.The North Carolina Department of Health and Human Services released their interim COVID-19 vaccination plan Friday, once one is available.

North Carolina unveils plan to deploy coronavirus vaccine

The minister posted a picture of herself receiving the vaccine on her official Instagram account.The minister posted a picture of herself receiving the vaccine on her official Instagram account.

Photo: UAE's youth minister receives Covid-19 vaccine shot - News | Khaleej Times

Scientists have warned that governments and tech firms need to tackle coronavirus misinformation.Scientists have warned that governments and tech firms need to tackle coronavirus misinformation.

Queen could help boost public’s trust in coronavirus vaccine, expert says | ITV News

Government adviser Professor Heidi Larson has told ministers it would be "really really smart" to use her majesty to fight against dangerous anti-vaccine conspiracy theories Government adviser Professor Heidi Larson has told ministers it would be "really really smart" to use her majesty to fight against dangerous anti-vaccine conspiracy theories

The Queen may be used by government to boost public trust in new coronavirus vaccines - Daily Star

Clinical trials of the coronavirus vaccine have involved 640 peopleClinical trials of the coronavirus vaccine have involved 640 people

Chinese Covid-19 vaccine candidate safe, early reports say | Metro News

Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.

China rapidly expands use of experimental COVID-19 vaccines | World News,The Indian Express

Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.

China rapidly expands use of experimental COVID-19 vaccines | World News,The Indian Express

China has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said theChina has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said the

CoronaVac, the Beijing-based Sinovac Biotech’s vaccine, is being offered in Jiaxing in eastern China’s Zhejiang province to care givers, especially epidemic-prevention workers, public service personnel and port inspectors.CoronaVac, the Beijing-based Sinovac Biotech’s vaccine, is being offered in Jiaxing in eastern China’s Zhejiang province to care givers, especially epidemic-prevention workers, public service personnel and port inspectors.

Covid-19 vaccine offered by Chinese city for emergency use costs $60 - world news - Hindustan Times

Hope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet Infectious Disease, is based on small early phase randomised clinical trials involving 640 participants. The vaccine candidate is based on inactivated coronavirus. Scientists said thoseHope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet

Hope for coronavirus vaccine boosted as scientists say Chinese jab safe and produces immune response | London Evening Standard

Access Denied

RUSSIA has approved its second coronavirus vaccine for general use from the public, but has again not subjected the drug to mass safety testingRUSSIA has approved its second coronavirus vaccine for general use from the public, but has again not subjected the drug to mass safety testing

Coronavirus vaccine shock as Russia approves SECOND jab without safety tests | World | News | Express.co.uk

A division of Chinese state-run Sinopharm Group Co Ltd that is developing two COVID-19 vaccines is offering them for free to Chinese students going abroad for higher studies, the Wall Street Journal reported https://on.wsj.com/3iWzvYJ on Wednesday.A division of Chinese state-run Sinopharm Group Co Ltd that is developing two COVID-19 vaccines is offering them for free to Chinese students going abroad for higher studies, the Wall Street Journal reported https://on.wsj.com/3iWzvYJ on Wednesday.

China's Sinopharm offers experimental COVID-19 vaccines to students - WSJ | Reuters

In August, Russia registered the world’s first vaccine against the coronavirus, which was highly praised by health experts across the globe and evaluated in the...In August, Russia registered the world’s first vaccine against the coronavirus, which was highly praised by health experts across the globe and evaluated in the...

'No Adverse Effects': Russian Minister on Why He Chose COVID Vaccine Based on Human Adenovirus - Sputnik International

Chinese company offers coronavirus vaccine to studentsChinese company offers coronavirus vaccine to students

Chinese company offers coronavirus vaccine to students | Taiwan News

BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...

Study: Covid-19 vaccine candidate from China’s CNBG shows promise in human test | Life | Malay Mail

While the U.S. and Europe await the results of large-scale clinical trials before deploying coronavirus vaccines, some other nations are moving much faster with emergency-use rollouts of experimental Chinese and Russian candidates.While the U.S. and Europe await the results of large-scale clinical trials before deploying coronavirus vaccines, some other nations are moving much faster with emergency-use rollouts of experimental Chinese and Russian candidates.

Russia, China Rush to Fill Covid-19 Vaccine Void - WSJ

One of China's front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage ...One of China's front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage ...

COVID-19 vaccine candidate from China's CNBG shows promise in human test, study shows - CNA

It has only been tested in 100 people, and there's no published data.It has only been tested in 100 people, and there's no published data.

Putin touts second dubious approval of an unproven COVID-19 vaccine | Ars Technica

It has only been tested in 100 people, and there's no published data.It has only been tested in 100 people, and there's no published data.

Putin touts second dubious approval of an unproven COVID-19 vaccine | Ars Technica

Russian President Vladimir Putin on Wednesday announced the registration of the country’s second Covid-19 vaccine, called "EpiVacCorona."The second Russian Covid-19 vaccine to get regulatory approval has been developed by the country’s Vector State Research Centre of Virology and Biotechnology.

Russia approves second Covid-19 vaccine 'EpiVacCorona'

Registration of the third candidate preparation is due shortly, according to the presidentRegistration of the third candidate preparation is due shortly, according to the president

Vector center registers second Russian COVID-19 vaccine - Society & Culture - TASS

Vector center registers second Russian COVID-19 vaccine

Bloomberg - Are you a robot?

The Russian government is exploiting a scientific win for propaganda purposes. Its subversive action could encourage an equally reckless push by the US to approve a vaccine before the November elections.

Russia’s Sputnik Vaccine Stunt Could Cast a Long Shadow - The Wire Science

A state-owned Chinese company is giving away free shots of its unproven COVID-19 vaccines to students going abroad to study, according to The Wall Street Journal.A state-owned Chinese company is giving away free shots of its unproven COVID-19 vaccines to students going abroad to study, according to The Wall Street Journal.

A Chinese state-owned company is reportedly giving free shots of its unproven COVID-19 vaccine to students going abroad | Business Insider